Found: 6
Select item for more details and to access through your institution.
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 359, doi. 10.1007/s10637-006-9031-6
- By:
- Publication type:
- Article
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 357, doi. 10.1007/s10637-007-9047-6
- By:
- Publication type:
- Article
A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series.
- Published in:
- 2018
- By:
- Publication type:
- case study
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity.
- Published in:
- Oncologist, 2016, v. 21, n. 7, p. 795, doi. 10.1634/theoncologist.2015-0480
- By:
- Publication type:
- Article
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 5, p. 1122, doi. 10.1111/bcp.12665
- By:
- Publication type:
- Article